Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis

Figure 1

patient disposition in the study. Of 792 patients randomized and took study medication (ITT cohort), 736 patients completed the study. The most common reason for withdrawal from the trial was an adverse event, followed by lack of drug efficacy and non-compliance with the protocol.